This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (63)  • Contact me when this article is cited  Related Content  • Similar articles in this journal

Evidence of Stable Responses Over Three Decades

Ross J. Baldessarini, MD; Leonardo Tondo, MD

Arch Gen Psychiatry. 2000;57:187-190.

To evaluate whether lithium treatment has been overvalued and may be no longer as effective as formerly, we reviewed published reports on long-term lithium treatment (1970-1996) as well as analyzing its clinical effects on 360 patients with DSM-IV bipolar disorder who entered into lithium maintenance monotherapy after 1970. Neither reported recurrence rates nor average proportions of time ill nor patient improvement of 50% or more during lithium maintenance therapy in a stable clinic setting has changed significantly since the 1970s. Unfavorable results in some settings may reflect accumulation over time of patients with complex, less treatment-responsive illnesses. Lithium is unmatched in research support for long-term clinical effectiveness against morbidity and mortality associated with depression or mania in bipolar I and II disorders. Data evaluated herein did not support suggestions that benefits of lithium have been exaggerated in the past or have been lost recently.

From the International Consortium for Bipolar Disorder Research, the Consolidated Department of Psychiatry, Harvard Medical School, Boston, Mass, and the Bipolar and Psychotic Disorders Program, McLean Division of Massachusetts General Hospital, Belmont, Mass (Drs Baldessarini and Tondo); and the Department of Psychology, University of Cagliari and Centro Lucio Bini, Cagliari, Sardinia (Dr Tondo).

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Olanzapine - relapse prevention following mania.
Dando and Tohen
J Psychopharmacol 2006;20:31-38.
ABSTRACT  

Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder
Chisholm et al.
Br. J. Psychiatry 2005;187:559-567.
ABSTRACT | FULL TEXT  

Olanzapine Versus Lithium in the Maintenance Treatment of Bipolar Disorder: A 12-Month, Randomized, Double-Blind, Controlled Clinical Trial
Tohen et al.
Am. J. Psychiatry 2005;162:1281-1290.
ABSTRACT | FULL TEXT  

Relapse Prevention and Bipolar Disorder: A Focus on Bipolar Depression
Rapaport and Hales
Focus 2003;1:15-31.
ABSTRACT | FULL TEXT  

Lithium: An Orphan Drug
Rosenthal
Arch Gen Psychiatry 2001;58:973-973.
FULL TEXT  

Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers
MANJI et al.
Br. J. Psychiatry 2001;178 :s107-s119.
ABSTRACT | FULL TEXT  

Long-term clinical effectiveness of lithium maintenance treatment in types I and II bipolar disorders
TONDO et al.
Br. J. Psychiatry 2001;178 :s184-s190.
ABSTRACT | FULL TEXT  

Maintenance Treatment in Bipolar Disorder
Baldessarini et al.
Arch Gen Psychiatry 2000;57:490-492.
FULL TEXT